Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

White matter alterations in early Parkinson's disease: role of motor symptom lateralization.

Pelizzari L, Di Tella S, Laganà MM, Bergsland N, Rossetto F, Nemni R, Baglio F.

Neurol Sci. 2020 Feb;41(2):357-364. doi: 10.1007/s10072-019-04084-y. Epub 2019 Oct 24.

PMID:
31650438
2.

Herpes simplex virus-1 (HSV-1) infection induces a potent but ineffective IFN-λ production in immune cells of AD and PD patients.

La Rosa F, Agostini S, Bianchi A, Nemni R, Piancone F, Marventano I, Mancuso R, Saresella M, Clerici M.

J Transl Med. 2019 Aug 27;17(1):286. doi: 10.1186/s12967-019-2034-9.

3.

The PILRA G78R Variant Correlates with Higher HSV-1-Specific IgG Titers in Alzheimer's Disease.

Agostini S, Costa AS, Mancuso R, Guerini FR, Nemni R, Clerici M.

Cell Mol Neurobiol. 2019 Nov;39(8):1217-1221. doi: 10.1007/s10571-019-00712-5. Epub 2019 Jul 11.

PMID:
31297637
4.

Combined Assessment of Diffusion Parameters and Cerebral Blood Flow Within Basal Ganglia in Early Parkinson's Disease.

Pelizzari L, Laganà MM, Di Tella S, Rossetto F, Bergsland N, Nemni R, Clerici M, Baglio F.

Front Aging Neurosci. 2019 Jun 4;11:134. doi: 10.3389/fnagi.2019.00134. eCollection 2019.

5.

Cerebrovascular reactivity and its correlation with age in patients with multiple sclerosis.

Pelizzari L, Laganà MM, Baglio F, Bergsland N, Cecconi P, Viotti S, Pugnetti L, Nemni R, Baselli G, Clerici M, Mendozzi L.

Brain Imaging Behav. 2019 Jun 7. doi: 10.1007/s11682-019-00132-5. [Epub ahead of print]

PMID:
31175576
6.

Brain networks construction using Bayes FDR and average power function.

Quatto P, Margaritella N, Costantini I, Baglio F, Garegnani M, Nemni R, Pugnetti L.

Stat Methods Med Res. 2020 Mar;29(3):866-878. doi: 10.1177/0962280219844288. Epub 2019 May 14.

PMID:
31088219
7.

SNARE Complex Polymorphisms Associate with Alterations of Visual Selective Attention in Alzheimer's Disease.

Costa AS, Guerini FR, Arosio B, Galimberti D, Zanzottera M, Bianchi A, Nemni R, Clerici M.

J Alzheimers Dis. 2019;69(1):179-188. doi: 10.3233/JAD-190147.

PMID:
30958380
8.

An ecological measure to screen executive functioning in MS: the Picture Interpretation Test (PIT) 360°.

Realdon O, Serino S, Savazzi F, Rossetto F, Cipresso P, Parsons TD, Cappellini G, Mantovani F, Mendozzi L, Nemni R, Riva G, Baglio F.

Sci Rep. 2019 Apr 5;9(1):5690. doi: 10.1038/s41598-019-42201-1.

9.

Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson's disease.

Pelizzari L, Laganà MM, Rossetto F, Bergsland N, Galli M, Baselli G, Clerici M, Nemni R, Baglio F.

Ther Adv Neurol Disord. 2019 Mar 21;12:1756286419838354. doi: 10.1177/1756286419838354. eCollection 2019.

10.

SNAP-25 in Serum Is Carried by Exosomes of Neuronal Origin and Is a Potential Biomarker of Alzheimer's Disease.

Agliardi C, Guerini FR, Zanzottera M, Bianchi A, Nemni R, Clerici M.

Mol Neurobiol. 2019 Aug;56(8):5792-5798. doi: 10.1007/s12035-019-1501-x. Epub 2019 Jan 24.

PMID:
30680692
11.

Are Cerebral Perfusion and Atrophy Linked in Multiple Sclerosis? Evidence for a Multifactorial Approach to Assess Neurodegeneration.

Laganá MM, Mendozzi L, Pelizzari L, Bergsland NP, Pugnetti L, Cecconi P, Baselli G, Clerici M, Nemni R, Baglio F.

Curr Neurovasc Res. 2018;15(4):282-291. doi: 10.2174/1567202616666181123164235.

PMID:
30468125
12.

Association between Hippocampal Shape, Neuroinflammation, and Cognitive Decline in Alzheimer's Disease.

Cabinio M, Saresella M, Piancone F, LaRosa F, Marventano I, Guerini FR, Nemni R, Baglio F, Clerici M.

J Alzheimers Dis. 2018;66(3):1131-1144. doi: 10.3233/JAD-180250.

PMID:
30400090
13.

SNAP25 Gene Polymorphisms Protect Against Parkinson's Disease and Modulate Disease Severity in Patients.

Agliardi C, Guerini FR, Zanzottera M, Riboldazzi G, Zangaglia R, Sturchio A, Casali C, Di Lorenzo C, Minafra B, Nemni R, Clerici M.

Mol Neurobiol. 2019 Jun;56(6):4455-4463. doi: 10.1007/s12035-018-1386-0. Epub 2018 Oct 17.

PMID:
30334187
14.

Cognitive and Affective Theory of Mind in Mild Cognitive Impairment and Parkinson's Disease: Preliminary Evidence from the Italian Version of the Yoni Task.

Rossetto F, Castelli I, Baglio F, Massaro D, Alberoni M, Nemni R, Shamay-Tsoory S, Marchetti A.

Dev Neuropsychol. 2018;43(8):764-780. doi: 10.1080/87565641.2018.1529175. Epub 2018 Oct 9.

PMID:
30299987
15.

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.

Lawlor B, Segurado R, Kennelly S, Olde Rikkert MGM, Howard R, Pasquier F, Börjesson-Hanson A, Tsolaki M, Lucca U, Molloy DW, Coen R, Riepe MW, Kálmán J, Kenny RA, Cregg F, O'Dwyer S, Walsh C, Adams J, Banzi R, Breuilh L, Daly L, Hendrix S, Aisen P, Gaynor S, Sheikhi A, Taekema DG, Verhey FR, Nemni R, Nobili F, Franceschi M, Frisoni G, Zanetti O, Konsta A, Anastasios O, Nenopoulou S, Tsolaki-Tagaraki F, Pakaski M, Dereeper O, de la Sayette V, Sénéchal O, Lavenu I, Devendeville A, Calais G, Crawford F, Mullan M; NILVAD Study Group.

PLoS Med. 2018 Sep 24;15(9):e1002660. doi: 10.1371/journal.pmed.1002660. eCollection 2018 Sep.

16.

Selection Processing in Noun and Verb Production in Left- and Right-Sided Parkinson's Disease Patients.

Di Tella S, Baglio F, Cabinio M, Nemni R, Traficante D, Silveri MC.

Front Psychol. 2018 Jul 20;9:1241. doi: 10.3389/fpsyg.2018.01241. eCollection 2018.

17.

HSV-1-Specific IgG Subclasses Distribution and Serum Neutralizing Activity in Alzheimer's Disease and in Mild Cognitive Impairment.

Agostini S, Mancuso R, Hernis A, Costa AS, Nemni R, Clerici M.

J Alzheimers Dis. 2018;63(1):131-138. doi: 10.3233/JAD-170966.

PMID:
29578484
18.

TNF-α -308 G/A and -238 G/A promoter polymorphisms and sporadic Parkinson's disease in an Italian cohort.

Agliardi C, Guerini FR, Zanzottera M, Riboldazzi G, Zangaglia R, Bono G, Casali C, Di Lorenzo C, Pacchetti C, Nemni R, Clerici M.

J Neurol Sci. 2018 Feb 15;385:45-48. doi: 10.1016/j.jns.2017.12.011. Epub 2017 Dec 11.

PMID:
29406912
19.

Social Decision Making in Adolescents and Young Adults: Evidence From the Ultimatum Game and Cognitive Biases.

Marchetti A, Baglio F, Castelli I, Griffanti L, Nemni R, Rossetto F, Valle A, Zanette M, Massaro D.

Psychol Rep. 2019 Feb;122(1):135-154. doi: 10.1177/0033294118755673. Epub 2018 Feb 5.

PMID:
29402178
20.

Immune and Imaging Correlates of Mild Cognitive Impairment Conversion to Alzheimer's Disease.

La Rosa F, Saresella M, Baglio F, Piancone F, Marventano I, Calabrese E, Nemni R, Ripamonti E, Cabinio M, Clerici M.

Sci Rep. 2017 Dec 1;7(1):16760. doi: 10.1038/s41598-017-16754-y.

21.

Picture Interpretation Test (PIT) 360°: An Innovative Measure of Executive Functions.

Serino S, Baglio F, Rossetto F, Realdon O, Cipresso P, Parsons TD, Cappellini G, Mantovani F, De Leo G, Nemni R, Riva G.

Sci Rep. 2017 Nov 22;7(1):16000. doi: 10.1038/s41598-017-16121-x.

22.

Modulation of Immune Responses to Herpes Simplex Virus Type 1 by IFNL3 and IRF7 Polymorphisms: A Study in Alzheimer's Disease.

Costa AS, Agostini S, Guerini FR, Mancuso R, Zanzottera M, Ripamonti E, Racca V, Nemni R, Clerici M.

J Alzheimers Dis. 2017;60(3):1055-1063. doi: 10.3233/JAD-170520.

PMID:
28984602
23.

Sympathetic skin response in multiple sclerosis: a meta-analysis of case-control studies.

Margaritella N, Mendozzi L, Garegnani M, Gilardi E, Nemni R, Pugnetti L.

Neurol Sci. 2018 Jan;39(1):45-52. doi: 10.1007/s10072-017-3111-6. Epub 2017 Sep 29. Review.

24.

REST, a master regulator of neurogenesis, evolved under strong positive selection in humans and in non human primates.

Mozzi A, Guerini FR, Forni D, Costa AS, Nemni R, Baglio F, Cabinio M, Riva S, Pontremoli C, Clerici M, Sironi M, Cagliani R.

Sci Rep. 2017 Aug 25;7(1):9530. doi: 10.1038/s41598-017-10245-w.

25.

Technology-enhanced multi-domain at home continuum of care program with respect to usual care for people with cognitive impairment: the Ability-TelerehABILITation study protocol for a randomized controlled trial.

Realdon O, Rossetto F, Nalin M, Baroni I, Cabinio M, Fioravanti R, Saibene FL, Alberoni M, Mantovani F, Romano M, Nemni R, Baglio F.

BMC Psychiatry. 2016 Nov 25;16(1):425.

26.

High avidity HSV-1 antibodies correlate with absence of amnestic Mild Cognitive Impairment conversion to Alzheimer's disease.

Agostini S, Mancuso R, Baglio F, Cabinio M, Hernis A, Costa AS, Calabrese E, Nemni R, Clerici M.

Brain Behav Immun. 2016 Nov;58:254-260. doi: 10.1016/j.bbi.2016.07.153. Epub 2016 Jul 25.

PMID:
27470229
27.

ApoE and SNAP-25 Polymorphisms Predict the Outcome of Multidimensional Stimulation Therapy Rehabilitation in Alzheimer's Disease.

Guerini FR, Farina E, Costa AS, Baglio F, Saibene FL, Margaritella N, Calabrese E, Zanzottera M, Bolognesi E, Nemni R, Clerici M.

Neurorehabil Neural Repair. 2016 Oct;30(9):883-93. doi: 10.1177/1545968316642523. Epub 2016 Apr 13.

PMID:
27075583
28.

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease.

Saresella M, La Rosa F, Piancone F, Zoppis M, Marventano I, Calabrese E, Rainone V, Nemni R, Mancuso R, Clerici M.

Mol Neurodegener. 2016 Mar 3;11:23. doi: 10.1186/s13024-016-0088-1.

29.

Misidentification Delusions: Prevalence in Different Types of Dementia and Validation of a Structured Questionnaire.

Perini G, Carlini A, Pomati S, Alberoni M, Mariani C, Nemni R, Farina E.

Alzheimer Dis Assoc Disord. 2016 Oct-Dec;30(4):331-337.

PMID:
26859554
30.

Theory of Mind and the Whole Brain Functional Connectivity: Behavioral and Neural Evidences with the Amsterdam Resting State Questionnaire.

Marchetti A, Baglio F, Costantini I, Dipasquale O, Savazzi F, Nemni R, Sangiuliano Intra F, Tagliabue S, Valle A, Massaro D, Castelli I.

Front Psychol. 2015 Dec 10;6:1855. doi: 10.3389/fpsyg.2015.01855. eCollection 2015.

31.

Mind-Reading Ability and Structural Connectivity Changes in Aging.

Cabinio M, Rossetto F, Blasi V, Savazzi F, Castelli I, Massaro D, Valle A, Nemni R, Clerici M, Marchetti A, Baglio F.

Front Psychol. 2015 Nov 26;6:1808. doi: 10.3389/fpsyg.2015.01808. eCollection 2015.

32.

Lack of evidence for a role of HHV-6 in the pathogenesis of Alzheimer's disease.

Agostini S, Mancuso R, Baglio F, Cabinio M, Hernis A, Guerini FR, Calabrese E, Nemni R, Clerici M.

J Alzheimers Dis. 2016;49(1):229-35. doi: 10.3233/JAD-150464.

PMID:
26444787
33.

Effective artifact removal in resting state fMRI data improves detection of DMN functional connectivity alteration in Alzheimer's disease.

Griffanti L, Dipasquale O, Laganà MM, Nemni R, Clerici M, Smith SM, Baselli G, Baglio F.

Front Hum Neurosci. 2015 Aug 11;9:449. doi: 10.3389/fnhum.2015.00449. eCollection 2015.

34.

High-Dimensional ICA Analysis Detects Within-Network Functional Connectivity Damage of Default-Mode and Sensory-Motor Networks in Alzheimer's Disease.

Dipasquale O, Griffanti L, Clerici M, Nemni R, Baselli G, Baglio F.

Front Hum Neurosci. 2015 Feb 3;9:43. doi: 10.3389/fnhum.2015.00043. eCollection 2015.

35.

Relationship between herpes simplex virus-1-specific antibody titers and cortical brain damage in Alzheimer's disease and amnestic mild cognitive impairment.

Mancuso R, Baglio F, Agostini S, Cabinio M, Laganà MM, Hernis A, Margaritella N, Guerini FR, Zanzottera M, Nemni R, Clerici M.

Front Aging Neurosci. 2014 Oct 15;6:285. doi: 10.3389/fnagi.2014.00285. eCollection 2014.

36.

Abnormal development of sensory-motor, visual temporal and parahippocampal cortex in children with learning disabilities and borderline intellectual functioning.

Baglio F, Cabinio M, Ricci C, Baglio G, Lipari S, Griffanti L, Preti MG, Nemni R, Clerici M, Zanette M, Blasi V.

Front Hum Neurosci. 2014 Oct 15;8:806. doi: 10.3389/fnhum.2014.00806. eCollection 2014.

37.

A global immune deficit in Alzheimer's disease and mild cognitive impairment disclosed by a novel data mining process.

Gironi M, Borgiani B, Farina E, Mariani E, Cursano C, Alberoni M, Nemni R, Comi G, Buscema M, Furlan R, Grossi E.

J Alzheimers Dis. 2015;43(4):1199-213. doi: 10.3233/JAD-141116.

PMID:
25201785
38.

Possible association between SNAP-25 single nucleotide polymorphisms and alterations of categorical fluency and functional MRI parameters in Alzheimer's disease.

Guerini FR, Agliardi C, Sironi M, Arosio B, Calabrese E, Zanzottera M, Bolognesi E, Ricci C, Costa AS, Galimberti D, Griffanti L, Bianchi A, Savazzi F, Mari D, Scarpini E, Baglio F, Nemni R, Clerici M.

J Alzheimers Dis. 2014;42(3):1015-28. doi: 10.3233/JAD-140057.

PMID:
25024311
39.

Individual Thresholding of Voxel-based Functional Connectivity Maps. Estimation of Random Errors by Means of Surrogate Time Series.

Griffanti L, Baglio F, Laganà MM, Preti MG, Cecconi P, Clerici M, Nemni R, Baselli G.

Methods Inf Med. 2015;54(3):227-31. doi: 10.3414/ME13-02-0042. Epub 2014 May 9.

PMID:
24816333
40.

Multistimulation group therapy in Alzheimer's disease promotes changes in brain functioning.

Baglio F, Griffanti L, Saibene FL, Ricci C, Alberoni M, Critelli R, Villanelli F, Fioravanti R, Mantovani F, D'amico A, Cabinio M, Preti MG, Nemni R, Farina E.

Neurorehabil Neural Repair. 2015 Jan;29(1):13-24. doi: 10.1177/1545968314532833. Epub 2014 Apr 29.

PMID:
24788581
41.

A novel approach of groupwise fMRI-guided tractography allowing to characterize the clinical evolution of Alzheimer's disease.

Preti MG, Makris N, Papadimitriou G, Laganà MM, Griffanti L, Clerici M, Nemni R, Westin CF, Baselli G, Baglio F.

PLoS One. 2014 Mar 17;9(3):e92026. doi: 10.1371/journal.pone.0092026. eCollection 2014.

42.

The EP-score to assess treatment efficacy in RRMS patients: a preliminary study.

Margaritella N, Mendozzi L, Garegnani M, Nemni R, Gilardi E, Pugnetti L.

Int J Neurosci. 2015 Jan;125(1):38-42. doi: 10.3109/00207454.2014.904305. Epub 2014 May 8.

PMID:
24628579
43.

Neuroinflammation and brain functional disconnection in Alzheimer's disease.

Baglio F, Saresella M, Preti MG, Cabinio M, Griffanti L, Marventano I, Piancone F, Calabrese E, Nemni R, Clerici M.

Front Aging Neurosci. 2013 Nov 25;5:81. doi: 10.3389/fnagi.2013.00081. eCollection 2013.

44.

Growth hormone and disease severity in early stage of multiple sclerosis.

Gironi M, Solaro C, Meazza C, Vaghi M, Montagna L, Rovaris M, Batocchi AP, Nemni R, Albertini R, Zaffaroni M, Bozzola M.

Mult Scler Int. 2013;2013:836486. doi: 10.1155/2013/836486. Epub 2013 Oct 23.

45.

Titers of herpes simplex virus type 1 antibodies positively correlate with grey matter volumes in Alzheimer's disease.

Mancuso R, Baglio F, Cabinio M, Calabrese E, Hernis A, Nemni R, Clerici M.

J Alzheimers Dis. 2014;38(4):741-5. doi: 10.3233/JAD-130977.

PMID:
24072067
46.

A complex proinflammatory role for peripheral monocytes in Alzheimer's disease.

Saresella M, Marventano I, Calabrese E, Piancone F, Rainone V, Gatti A, Alberoni M, Nemni R, Clerici M.

J Alzheimers Dis. 2014;38(2):403-13. doi: 10.3233/JAD-131160.

PMID:
23979026
47.

A novel approach of fMRI-guided tractography analysis within a group: construction of an fMRI-guided tractographic atlas.

Preti MG, Makris N, Laganà MM, Papadimitriou G, Baglio F, Griffanti L, Nemni R, Cecconi P, Westin CF, Baselli G.

Conf Proc IEEE Eng Med Biol Soc. 2012;2012:2283-6. doi: 10.1109/EMBC.2012.6346418.

PMID:
23366379
48.

A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis.

Gironi M, Saresella M, Rovaris M, Vaghi M, Nemni R, Clerici M, Grossi E.

Immun Ageing. 2013 Jan 10;10(1):1. doi: 10.1186/1742-4933-10-1.

49.

The evoked potentials score improves the identification of benign MS without cognitive impairment.

Margaritella N, Mendozzi L, Tronci F, Colicino E, Garegnani M, Nemni R, Gilardi E, Pugnetti L.

Eur J Neurol. 2013 Oct;20(10):1423-5. doi: 10.1111/ene.12071. Epub 2013 Jan 7.

PMID:
23293907
50.

Exploring the predictive value of the evoked potentials score in MS within an appropriate patient population: a hint for an early identification of benign MS?

Margaritella N, Mendozzi L, Garegnani M, Nemni R, Colicino E, Gilardi E, Pugnetti L.

BMC Neurol. 2012 Aug 22;12:80. doi: 10.1186/1471-2377-12-80.

Supplemental Content

Support Center